Loading
Latest filing published 03 Aug 2026 for Cue Biopharma, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
James M. Ahlers has a single filing on record, published on 3 August 2026: a share grant in Cue Biopharma, Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration